Humacyte, Inc.·4

Sep 6, 4:14 PM ET

Binder Gordon M 4

4 · Humacyte, Inc. · Filed Sep 6, 2022

Insider Transaction Report

Form 4
Period: 2022-09-02
Transactions
  • Purchase

    Common Stock

    2022-09-02$4.40/sh+61,841$272,100110,000 total
Footnotes (1)
  • [F1]The shares were purchased in multiple transactions at per share prices ranging from $4.20 to $4.70. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    wf-form4_166249526500566.xmlPrimary

    FORM 4